Navigation Links
Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
Date:11/9/2009

ALISO VIEJO, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations at two upcoming investor conferences in New York City.

The first presentation will be made at the Lazard Capital Markets Sixth Annual Healthcare Conference at 1:40 pm EST on Tuesday, November 17. The conference will be held at the St. Regis Hotel November 17-18.

The second presentation will be made at the 21st Annual Piper Jaffray Health Care Conference at 10:30 am EST on Wednesday, December 2. The conference will be held at the New York Palace Hotel December 1-2.

Live webcasts of the Company's presentations at the conferences will be available via a link provided at http://www.clarientinc.com/investor. Archived replays of the presentations will also be available shortly after the presentation time for a period of at least 60 days.

About Clarient

Clarient combines innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by collaborating with the healthcare community to translate cancer research and development into better patient care. Clarient's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine has created the need for a centralized resource which provides leading oncology diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory, which provides the most advanced oncology testi
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...TICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstC... ) today announced that it has received 510(k) cle...(FDA) and CE Mark approval to market its WallFlex&...ment of malignant esophageal strictures (obstructi...or non-resectable esophageal cancer. ,, (Photo...
(Date:11/20/2009)...OUSTON, Nov. 20 Cyberoni... Moore, President and Chief Executive Officer, and...t at the 21st Annual Piper Jaffray Health Care Con... at 12:00 PM EST. The conference session and webc...e presented. Piper Jaffray will host a webcast of...
(Date:11/20/2009)...KLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall/ -...) today announced the completion of its acquisitio...company that develops and manufactures molecular d...n May 2009, BD and HandyLab announced an exclusive...ecular assays on the HandyLab Jaguar(TM) platform,...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Arizona researchers to sequence West African rice strain 51528 1Arizona researchers to sequence West African rice strain 51528 2Arizona researchers to sequence West African rice strain 51528 3Herbicide diversity needed to keep Roundup effective 9243 1Herbicide diversity needed to keep Roundup effective 9243 2Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 51527 1Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 51527 2Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 51527 3
... stress-related TMJ problems and create healthy, p... Feldenkrais Movement Institute announces the rele...part of its The Intelligent Body(R) DIY-series... The program offers sufferers of jaw pain an inexp...ce chronic tension in the jaw, face, neck and uppe...
... New Alliance a Key Step for OBT to Broaden its Ex...ford BioTherapeutics (OBT) today announced a strat...velop and commercialise novel, therapeutic,antibod...ecurring forms of,cancer. , Under the alliance...t,selected OBT targets. In parallel OBT will devel...
Other Medicine Technology:Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 2Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 3Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 2Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 3
(Date:11/20/2009)...20 Missouri state employees in the... now have the option to choose Mercy Health Plans ...souri Consolidated Health Care Plan (MCHCP) and Me...ntral Missouri regions include the following count..., Douglas, Greene, Hickory, Howell, Jasper, Lacled...
(Date:11/20/2009)...20 The Louisiana As... Louisianians could experience higher health care ...onsidered by Congress should become law. ,, Acc...AHP, "Louisiana health plans have supported compre...the national debate. Our plans have offered signi...
(Date:11/20/2009)... The US government repo...to get enough food to eat. This startling statist... are rapidly aging into poverty. "Forced retireme... mean many have incomes that no longer cover the b...r women are particularly vulnerable," said Kate Wh...
(Date:11/20/2009)...20 Fear about the risk ...atients are not getting aortic valve replacement s...University of Michigan Health System. ,, Earli...omedian Robin Williams underwent aortic valve repl...out on the potentially life-saving surgery. ,, ...
(Date:11/20/2009)... POLITICO recently pu... and Manufacturers of America (PhRMA) Senior Vice...makes the case for health reform and reaffirm,s Ph...t. ,, Johnson states the plight of the uninsure...tes PhRMA,s position that everyone in America sh...
Breaking Medicine News(10 mins):Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2
...mpany cites food industry,s heightened concern abo... behind its new product, ATLANTA, Oct. 21 Someon...tore. An employee cuts his hand while cleaning equ...ey can,also be hazardous. Bodily fluids such as vo...
...SHINGTON, Oct. 21 A report,( http://www.firstfocu...ow,children are treated in the health care plans o...n and Barack Obama. The analysis identifies,both o...o comprehensive and affordable health care for eve...
... Wayport, Inc. announced t...offer public Internet access to Sun,s inpatient se...idge Healthcare Corporation, collectively operate ...8. , IRVING, Texas (Busi...
...NNEAPOLIS, Oct. 21 In a ceremony today at,the Air...orp. presented,Aero Med Spectrum Health with a mod...company,s 15 years of transporting patients with,S...er earlier,this year and is exhibiting the aircraf...
...ternet technology making a difference in the lives...painkillers and heroin., FARMINGTON, Conn., Oct. ...//www.naabt.org ) free and anonymous online matchi...sicians are allowed by law to prescribe this,treat...
...rth Stokes High School Vikings score the title of ...ire/ - Refueling and staying fit has,become second...High School.,The National Milk Mustache "got milk?...inated to be part of the,first-ever nationwide Ref...
Other Medicine News:Health News:Chemstar Corporation Responds to Industry Demand by Developing an All-In-One Bodily Fluid Clean-Up Kit 2Health News:New Report Analyzes How Children Fare in Candidates' Health Care Plans 2Health News:New Report Analyzes How Children Fare in Candidates' Health Care Plans 3Health News: Wayport Signs Agreement with Sun Healthcare Group to Enable Public Internet Access : Sun's Inpatient Services Subsidiaries to Utilize Public Applications Managed by Wayport 2Health News:Sikorsky Aircraft Recognizes Aero Med Spectrum Health Hospitals 2Health News:NAABT Patient/Physician Matching System A Success 2Health News:NAABT Patient/Physician Matching System A Success 3Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 2Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 3
...w standard in the field of hammertoe implants with...al grade silicone, these durable and lasting impla...lexibility while maintaining correct toe length an...iffnesses. Lengths are determined by the surgeon f...
...lant (KGTI) system offers the latest technology an...lant system is anatomically designed and restores ...nced reconstructive device for the first metatarso...stem consists of anatomically and biomechanically ...
...as been approved for use as an adjunctive therapy ...d adolescents over 12 years of age with partial on...medications. This indication is based on outcomes ...ured as median seizure reduction, was observed in ...
Epidural Spinal Electrodes
Medicine Products: